Ritholtz Wealth Management
RIGL icon

Ritholtz Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Ritholtz Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.18M Buy
107,590
+13,140
+14% +$570K 0.07% 190
2026
Q2 		$3.69M Buy
94,450
+16,064
+20% +$495K 0.06% 257
2026
Q1 		$2.12M Sell
78,386
-2,207
-3% -$74.2K 0.04% 365
2025
Q4 		$3.45M Buy
80,593
+72,999
+961% +$2.75M 0.06% 221
2025
Q3 		$215K Buy
+7,594
New +$227K ﹤0.01% 954

Other funds holding RIGL

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Burney Company
Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Ritholtz Wealth Management's RIGL Position: Q3 2026 in Review

Ritholtz Wealth Management increased its Rigel Pharmaceuticals (RIGL) stake by 14% in Q3 2026, buying an estimated $570K and bringing the position to 107,590 shares worth $5.18M. The position accounts for 0.07% of the portfolio, ranked #190.

Ritholtz Wealth Management first reported a position in RIGL in Q3 2025 and has held it in 5 quarters since. 63 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • Ritholtz Wealth Management held 107,590 shares of Rigel Pharmaceuticals worth $5.18M as of Q3 2026.
  • Ritholtz Wealth Management bought 13,140 Rigel Pharmaceuticals shares in Q3 2026, an estimated $570K.
  • Rigel Pharmaceuticals made up 0.07% of Ritholtz Wealth Management's portfolio in Q3 2026, its #190 holding.
  • Ritholtz Wealth Management first reported a position in Rigel Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 63 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.